Results 221 to 230 of about 97,638 (260)

Subpopulations in clinical samples of M. tuberculosis can give rise to rifampicin resistance and shed light on how resistance is acquired

Brunner VM, Fowler PW.
europepmc   +1 more source

Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study. [PDF]

Trop Dis Travel Med Vaccines
Gebremariam G, Kiros M, Hagos S, Hadush H, Gebremichael A, Gebrekirstos G, Tesfay A, Gebrewahid T, Berihu T, Gebremariam B.   +9 more
europepmc   +1 more source

Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey. [PDF]

BMC Infect Dis
Amin W, Gadallah M, Salah A, Rady M.
europepmc   +1 more source

Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021. [PDF]

BMC Infect Dis
Biset S, Teferi M, Alamirew H, Birhanu B, Dessie A, Aschale A, Haymanot A, Dejenie S, Gebremedhin T, Abebe W, Adane G.   +10 more
europepmc   +1 more source

Predicting rifampicin resistance inM. tuberculosisusing machine learning informed by protein structural and chemical features

Lynch CI, Adlard D, Fowler PW.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

The Lancet, 1993
Control of tuberculosis is threatened by widespread emergence of drug resistance in Mycobacterium tuberculosis. Understanding the molecular basis of resistance might lead to development of novel rapid methods for diagnosing drug resistance. We set out to determine the molecular basis of resistance to rifampicin, a major component of multidrug regimens ...
A, Telenti, P, Imboden, F, Marchesi, D, Lowrie, S, Cole, M J, Colston, L, Matter, K, Schopfer, T, Bodmer   +8 more
openaire   +4 more sources

Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis

Tuberculosis, 2013
Tuberculosis (TB) is still a major life-threatening infectious disease, within which especially the rise of multidrug resistant TB (MDR-TB) is currently worrying. This study focuses on mechanisms of development of rifampicin resistance, since rifampicin seems to play an important role in the development of MDR-TB.
de Knegt, G.J., Bruning, O., ten Kate, M.T., de Jong, M., van Belkum, A., Endtz, H.P., Breit, T.M., Bakker-Woudenberg, I.A.J.M., de Steenwinkel, J.E.M.   +8 more
openaire   +5 more sources

Acquired resistance to rifampicin by Mycobacterium kansasii

Tubercle, 1976
Two patients with Mycobacterium kansasii infection of the lung had organisms sensitive to rifampicin. Following treatment, essentially with rifampicin alone, the patients began to excrete organisms completely resistant to rifampicin. The ability of M. kansasii to acquire resistance to rifampicin during treatment has been clearly demonstrated.
P T, Davidson, R, Waggoner
openaire   +2 more sources

Rifampicin-resistant replication of coliphage N4 DNA

Nature, 1974
IT has recently been reported that rifampicin-sensitive RNA synthesis participates in the replication of bacterial1,2, episome or plasmid3–8 and phage7–11 DNA, presumably in a primer role during initiation. A more complex model of DNA replication may, however, be provided by the development of coliphage N4 (ref. 12).
G C, Schito, M, Giraldi, M, Toni
openaire   +2 more sources